How can artificial intelligence and machine learning be used to gather and process real-time manufacturing data?
New technologies, such as artificial intelligence and machine learning, are being employed by bio/pharma manufacturers to collect and analyze large amounts of process data in real-time. Hear an expert panel will discuss how this technology can be employed to optimize bio/pharma manufacturing and predictive maintenance.
This Editors’ Series panel discussion, moderated by the editors of Pharmaceutical Technology and BioPharm International, features Bikash Chatterjee, CEO, Pharmatech Associates; Pamela Docherty, life sciences industry manager, Siemens; Amos Dor, general manager of the Pharma team, automation products group, Applied Materials; and Bob Lenich, global life sciences director, Emerson.
The panel discussion—Technology Advances in Process Operations: Using Real-time Montioring and Artificial Intelligence to Optimize Manufacturing Operations was recorded during the 2020 Bio/Pharma Virtual Congress on Nov. 11, 2020.
EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes
December 3rd 2024EXO Biologics and its subsidiary, ExoXpert, have received GMP certification of a European exosomes manufacturing facility and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.